San Francisco Bay Area Venture Capital

Overlooked Opportunities

Avestria invests in women’s health and female-led life science ventures. We define women’s health as conditions affecting women exclusively (such as menopause), differently (such as cardiovascular disease), or disproportionately (such as Alzheimer’s).

Women are dominant in healthcare as founders, decision-makers, patients, spenders, and workers. And yet, only 1% of all venture capital funding for healthcare goes to women’s health companies according to PitchBook, and only 1.9% of all venture capital funding went to female founders in 2022.

To us, those figures show that these markets - women’s healthcare and female founders in the life sciences - are overlooked and undervalued.

We seek out early stage businesses with a product or service that utilizes technology and/or data to improve the quality of healthcare, improve access, lower costs or empower patients. In order to achieve commercial success, these businesses must be evidenced-based, induce clinical or behavioral change, possess scalable commercialization plans which account for healthcare policy, reimbursement and the existing infrastructure, and possess a sustainable competitive advantage.

As featured in…

Avestria Advisors

We know healthcare can be complicated. So, we asked the most intelligent medical doctors, scientists and regulatory experts we know.

Limited Partner Advisory Committees